You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》君聖泰醫藥(02511.HK)暗盤平開 現報11.62元
阿思達克 12-21 17:18
海普瑞(09989.HK)持股的君聖泰醫藥(02511.HK)將於明日(22日)首掛,輝立交易場資料顯示,君聖泰醫藥暗盤開報11.5元,與上市價持平,隨後曾升至11.88元,高出3.3%,現報11.62元,較上市價高超過1%,成交97.6萬股。 君聖泰醫藥為一間生物製藥公司,專注於就代謝及消化系統疾病的治療發現、開發及商業化多功能及多靶點療法。是次上市引入滄州創融為基石投資者,認購1.1億元公司股份。該公司預期,是次上市集資所得,有約80%都將為核心產品HTD1801的持續臨床研發活動提供資金。(gc/k) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account